107 related articles for article (PubMed ID: 24022406)
1. Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine.
Walter T; Wang L; Chuk K; Ng P; Tannock IF; Krzyzanowska MK
J Oncol Pharm Pract; 2014 Aug; 20(4):249-56. PubMed ID: 24022406
[TBL] [Abstract][Full Text] [Related]
2. Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O; Bourmaud A; Rioufol C; Colomban O; Guitton J; Schwiertz V; Regnier V; You B; Ranchon F; Maraval-Gaget R; Girard P; Chauvin F; Freyer G; Tod M; Henin E; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2018 Aug; 82(2):319-327. PubMed ID: 29948022
[TBL] [Abstract][Full Text] [Related]
3. Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.
Thivat E; Van Praagh I; Belliere A; Mouret-Reynier MA; Kwiatkowski F; Durando X; Mahammedi H; Dillies AF; Chollet P; Chevrier R
Oncology; 2013; 84(2):67-74. PubMed ID: 23128040
[TBL] [Abstract][Full Text] [Related]
4. [Validation of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment].
Baudot A; Oriol M; Tinquaut F; Moine V; Moriceau G; Muron T; Pacaut C; Collard O; Jacquin JP; Saban-Roche L; Bosacki C; Regnier-Denois V; Chauvin F; Bourmaud A
Bull Cancer; 2016 Mar; 103(3):241-51. PubMed ID: 26917467
[TBL] [Abstract][Full Text] [Related]
5. Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?
Font R; Espinas JA; Layos L; Martinez Villacampa M; Capdevila J; Tobeña M; Pisa A; Pericay C; Lezcano C; Fort E; Cardona I; Berga N; Solà J; Borras JM
Ann Oncol; 2017 Apr; 28(4):831-835. PubMed ID: 28327898
[TBL] [Abstract][Full Text] [Related]
6. Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program.
Vacher L; Thivat E; Poirier C; Mouret-Reynier MA; Chollet P; Devaud H; Dubray-Longeras P; Kwiatkowski F; Durando X; van Praagh-Doreau I; Chevrier R
Support Care Cancer; 2020 Jul; 28(7):3313-3322. PubMed ID: 31758323
[TBL] [Abstract][Full Text] [Related]
7. Adherence with capecitabine: A population-based analysis based on prescription refill data.
Kovacic L; de Haan N; de Lemos ML; Schaff K; Walisser S
J Oncol Pharm Pract; 2017 Jun; 23(4):284-287. PubMed ID: 27799607
[TBL] [Abstract][Full Text] [Related]
8. Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine.
Lau-Min KS; Marini J; Shah NK; Pucci D; Blauch AN; Cambareri C; Mooney B; Agarwal P; Johnston C; Schumacher RP; White K; Gabriel PE; Rosin R; Jacobs LA; Shulman LN
JCO Oncol Pract; 2024 Apr; 20(4):483-490. PubMed ID: 38237102
[TBL] [Abstract][Full Text] [Related]
9. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
Sommers RM; Miller K; Berry DL
Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer.
Visacri MB; Duarte NC; Lima TM; de Souza RN; Cobaxo TS; Teixeira JC; Barbosa CR; Dias LP; Tavares MG; Pincinato EC; Lima CS; Moriel P
J Oncol Pharm Pract; 2022 Mar; 28(2):326-336. PubMed ID: 33470162
[TBL] [Abstract][Full Text] [Related]
11. A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes.
Macintosh PW; Pond GR; Pond BJ; Leung V; Siu LL
Eur J Cancer Care (Engl); 2007 Jul; 16(4):380-6. PubMed ID: 17587364
[TBL] [Abstract][Full Text] [Related]
12. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
13. Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
Velligan DI; Wang M; Diamond P; Glahn DC; Castillo D; Bendle S; Lam YW; Ereshefsky L; Miller AL
Psychiatr Serv; 2007 Sep; 58(9):1187-92. PubMed ID: 17766564
[TBL] [Abstract][Full Text] [Related]
14. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.
Waterhouse DM; Calzone KA; Mele C; Brenner DE
J Clin Oncol; 1993 Jun; 11(6):1189-97. PubMed ID: 8501505
[TBL] [Abstract][Full Text] [Related]
15. Treatment Satisfaction and Adherence to Oral Chemotherapy in Patients With Cancer.
Jacobs JM; Pensak NA; Sporn NJ; MacDonald JJ; Lennes IT; Safren SA; Pirl WF; Temel JS; Greer JA
J Oncol Pract; 2017 May; 13(5):e474-e485. PubMed ID: 28398843
[TBL] [Abstract][Full Text] [Related]
16. Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
Bourmaud A; Henin E; Tinquaut F; Regnier V; Hamant C; Colomban O; You B; Ranchon F; Guitton J; Girard P; Freyer G; Tod M; Rioufol C; Trillet-Lenoir V; Chauvin F
BMC Res Notes; 2015 Jul; 8():291. PubMed ID: 26142140
[TBL] [Abstract][Full Text] [Related]
17. The use of capecitabine in daily practice: a study on adherence and patients' experiences.
Timmers L; Swart EL; Boons CC; Mangnus D; van de Ven PM; Peters GJ; Boven E; Hugtenburg JG
Patient Prefer Adherence; 2012; 6():741-8. PubMed ID: 23118530
[TBL] [Abstract][Full Text] [Related]
18. Adherence to oral chemotherapy: Challenges and opportunities.
Krikorian S; Pories S; Tataronis G; Caughey T; Chervinsky K; Lotz M; Shen AH; Weissmann L
J Oncol Pharm Pract; 2019 Oct; 25(7):1590-1598. PubMed ID: 30253725
[TBL] [Abstract][Full Text] [Related]
19. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
20. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
